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859Homing Sweet Homing:
OdysseyofHematopoieticStemCells
The lineage relationship between the blood cells found
in the developmentally successive hematopoietic or-
gans has remained elusive. In this issue of Immunity,
Murayama et al. (2006) track the migration of nascent
hematopoietic stem cells in zebrafish from their site
of origin to a newly described intermediate location.
Shifting hematopoietic sites during embryogenesis is
a common strategy used by a wide range of divergent
species, including flies, frogs, fish, and mammals, to
allow maturation and maintenance of hematopoietic
stem cell (HSC) populations by changing the cellular
microenvironment. In vertebrates, generation of the
blood system can be separated into two phases during
development (Godin and Cumano, 2002; Mikkola and
Orkin, 2006). The first, termed primitive, is transient
and primarily produces embryonic red cells within the
blood islands of the mammalian extraembryonic yolk
sac. This wave is quickly replaced by the definitive
phase, in which adult HSCs arise de novo within the em-
bryo proper in a region termed the aorta-gonad-meso-
nephros (AGM). The subsequent hematopoietic organs,
including the fetal liver, thymus, and bone marrow, are
thought to be seeded by HSCs migrating through circu-
lation. More recently, the placenta has been shown to
be an important site of definitive hematopoiesis (Gekas
et al., 2005; Ottersbach and Dzierzak, 2005), but
whether it generates HSCs in situ or is only seeded by
circulating HSCs remains unresolved. Although limited
evidence has suggested that the HSCs colonizing the
fetal organs, including the placenta, are derived fromthe AGM, direct evidence showing a lineal relationship
between these cells has been lacking.
Despite extensive evolutionary divergence between
zebrafish and mammals, the molecular pathways driv-
ing hematopoiesis and the approach of shifting anatom-
ical sites for generation of the blood system have been
highly conserved (Davidson and Zon, 2004). In this issue
of Immunity, Murayama et al. (2006) use the advantages
of the zebrafish system to describe hematopoiesis
in vivo and to show a direct lineage relationship be-
tween HSCs located in the AGM and the successive he-
matopoietic organs during larval development. Because
zebrafish embryos are generated in large numbers, are
easily accessible as a result of external fertilization,
and are optically transparent, this system is particularly
amenable to imaging-based studies that examine or-
ganogenesis in real time and to fate-mapping analyses.
Prior work has demonstrated that zebrafish undergo
both a primitive hematopoietic wave in the embryonic
lateral-plate mesoderm and a definitive phase in the
trunk dorsal aorta whereby cell types that are seemingly
equivalent to those found in the mammalian yolk sac
and AGM, respectively, are produced (Davidson and
Zon, 2004). Similar to the mouse bone marrow, the
kidney serves as the definitive site of hematopoiesis in
zebrafish; however, no intermediate hematopoietic or-
gans have previously been described. Here, the authors
visually illustrate the generation of a structure they term
the caudal hematopoietic tissue (CHT), which appears
to provide a transitional niche to support definitive HSC
expansion and maturation in the zebrafish.
Using differential interference contrast (DIC) optics
and electron mircroscopy, Murayama et al. describe
the formation of a complex vascular network generated
from a single-channel primitive caudal vein (pCV) via
angiogenesis in the tail (Figure 1). Between days 1 and
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860Figure 1. Zebrafish Use the CHT as an Intermediate Larval Hematopoietic Site
During CHT development, the single-channel CV sprouts via angiogenesis and begins extensive remodeling beginning by 1 day after fertilization.
By 48 hr, the CHT is a closed, highly vascular plexus that contains rapid blood flow. The plexus is surrounded by a mesenchymal stroma that
supports hematopoiesis. Although granulocytes are more abundant in the surrounding tissue in close apposition to CA, the other cell types
can be seen within the vascular lumens and extraluminal space. At 3 dpf, circulation has ceased throughout the plexus, but a newly formed de-
finitive CV contains rapid flow. An extensive fibroblast reticular cell network is found in the surrounding mesenchyme and on the dorsal wall of the
dCV. Timeline illustrates the shifting sites of hematopoiesis in zebrafish. Solid arrows show direct seeding as supported by lineage-tracing anal-
yses; dotted arrows suggest other possible routes that remain unexplored. Abbreviations are as follows: CHT, caudal hematopoietic tissue; CV,
caudal vein; CA, caudal artery.2 after fertilization, circulation persists throughout the
growing vascular plexus that contains hematopoietic
progenitor cells (CD41+ cells, probably HSCs) and mac-
rophages in the surrounding loose mesenchyme and
within luminal sinusoidal pockets. Prothrombocytes,
granulocytes (neutrophils and eosinophils), and lym-
phoid-committed precursors (LCP) were the first line-
ages seen in the abluminal space at day 2 in close appo-
sition to the caudal artery (CA). As the CHT evolves into
a more complicated structure in the day 3 zebrafish, it
physically separates the once juxtaposed CA and pCV
and supports massive expansion of blood progenitors
in the surrounding mesenchyme and lumen of the newly
formed definitive caudal vein (dCV). Simultaneously with
the appearance of proliferating blood progenitors, a
fibroblast reticular cell (FRC) matrix was observed in
close contact to the endothelial plexus that is specu-
lated to have arisen from adjacent mesenchyme to sup-
port hematopoietic cell proliferation and differentiation.
Although the height of CHT hematopoiesis was foundbetween 4 and 6 days, progenitor cells could still be
visualized at day 14, a time at which the first distinct
proerythroblasts and erythroblasts could be detected.
How does expansion and differentiation of hemato-
poietic progenitor cells in the zebrafish CHT compare
with the two main intermediate hematopoietic sites in
mammals? Both the placenta and fetal liver harbor phe-
notypically similar HSCs, but they appear to function
over separate developmental windows and promote
diverse hematopoietic fates. Although a strong compar-
ison was drawn between the mammalian fetal liver and
the zebrafish CHT (Murayama et al., 2006), there are also
several disparities, including cytoarchitecture and func-
tional activity, between these two microenvironments.
Although the fetal liver, much like the CHT, is rich in
single-lineage progenitor cells throughout develop-
ment, the cellular profile in each microenvironment ap-
pears different over time. Both the fetal liver and CHT
first contain enlarged sinusoids that house HSCs
and macrophages, but the fetal liver quickly becomes
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861largely erythropoietic as ellipsoidal foci composed of
definitive red-blood-cell ‘‘islands’’ arise in close contact
with hepatoblasts (Sasaki and Sonoda, 2000). In con-
trast to the cord-like configuration of hematopoietic
cells in the liver anlage, the cytological structure of the
CHT is highly vascular and has a surrounding mesen-
chymal-FRC network. Moreover, no erythroblasts were
found in the zebrafish CHT until the very late stages of
its activity, indicating that the molecular signals promot-
ing HSC differentiation down various lineal paths may
be quite different from those of the mammalian fetal
liver. More recently, the placenta has gained recognition
as a prominent pre-hepatic hematopoietic site in mam-
mals (Mikkola and Orkin, 2006). Like the CHT, the
placental labyrinth is a highly vascularized network of
fetal capillaries that drives rapid HSC expansion, pro-
motes lymphoid progenitor fates, and is devoid of
erythroid lineage differentiation. A major difference in
activity between these two niches, however, is that the
mammalian placenta also lacks myeloid differentiation,
whereas the zebrafish CHT promotes granulopoiesis.
Because the mammalian hematopoeitic organs show
similarities to the zebrafish larval site, it is interesting to
speculate that the single CHT niche serves the function
of both the mammalian fetal liver and placental microen-
vironments. It is currently unknown whether the pla-
centa produces HSCs in situ. One model is that AGM-
derived HSCs migrate to the placenta, where they are
nurtured and expanded temporarily prior to colonizing
the fetal liver, where more differentiation to single-
lineage progenitors takes place. Although the CHT cyto-
architecture is most similar to the placental labyrinth,
the progenitor fates generated appear to be a melding
of those found in the distinct mammalian fetal hemato-
poietic organs. It is possible that the zebrafish has co-
opted the CV plexus to first provide the signals needed
to support HSC expansion and lymphoid-committed
precursor specification as seen in the placenta and later
changes its molecular profile to promote myeloerythro-
poiesis as found in the fetal liver (Figure 1, bottom). This
scenario, which is further supported by the fate-mapping
results discussed below, predicts that the sequential
waves of hematopoiesis in the CHT mirror that seen in
mammalian placenta and fetal liver.
Lineage-tracing strategies are commonly used for re-
vealing developmental relationships between cells over
a determined period of time. These assays have been
extremely difficult to perform in mammalian embryos
because of their intra-uterine development and opaque
appearance. For example, so that the destination of
HSCs within the AGM in mice could be examined, an
inducible Cre-ER recombinase was placed under the
control of the stem cell leukemia (Tal1) enhancer and
activated via tamoxifen between E10.5 and 11.5, a time
when the AGM is most active (Gothert et al., 2005).
Although elegant, this system relies on promoter activity
from a particular locus and on achieving optimal tamox-
ifen amounts in the embryo for effective cell labeling.
Moreover, hematopoietic progenitors can already be
found in the fetal liver anlage at E10 (Sasaki and Sonoda,
2000), a time prior to initial Cre activation. Because
zebrafish are particularly amenable to classic fate-
mapping strategies, Murayama et al. directly labeled
hematopoietic cells in either the AGM (trunk) or theCHT (tail) of zebrafish animals and followed their fate
over time.
Via direct cell labeling, Murayama et al. suggest that
HSCs can be found in the interstitial space between
the CA and post-CV of the zebrafish trunk (DP-joint) in
an area analogous to the mammalian AGM. Labeled
DP-joint cells were shown to migrate to and expand in
the CHT first, then to move in a circulation-dependent
fashion to next seed the thymus, followed by the kidney
(Figure 1 bottom). Additionally, if CHT cells were labeled
instead of DP-joint cells, they were also found to initially
colonize the thymus and then the kidney. Although it is
attractive to speculate that AGM-derived HSCs must be
exposed to the CHT microenvironment before coloniz-
ing the thymus and kidney, the current data do not rule
out an AGM-to-thymus-and-kidney pathway indepen-
dent of the CHT niche.
Importantly, the lineage-tracing data indicated that
HSCs released from the AGM prior to day 2 have a fate
distinct from that of HSCs released after day 2. The first
wave generated granulocytes, macrophages, and lym-
phoid-committed precursors that seeded the CHT and
could later be tracked to the thymus, whereas only
the second set additionally colonized the kidney with
what is presumed to be the definitive HSC. Although
the difference in the CHT-lineage profile may reflect the
developmental potential of HSCs originally seeding the
site, it is plausible that the CHT microenvironment is
modified during development to meet the changing he-
matopoietic needs of larval life. As mentioned earlier, this
model suggests that the single CHT microenvironment
may be analogous to both the placental and fetal liver
niches of mammals and mirror their function in sequen-
tial order.
One important area of research for the future is the or-
igin of the adult hematopoietic cells of the bone marrow.
Specifically, do they arise from the AGM? This finding
was suggested by Xenopus experiments in which trip-
loid host embryos transplanted with diploid AGM cells
were later shown to harbor diploid adult blood (Turpen
et al., 1997). In the zebrafish, stable inducible cre-lox
systems could be used to fate map the AGM and CHT
and evaluate their adult contribution. Clearly, a compar-
ative approach across diverse phyla is necessary for
determining the origin of adult organ stem cells during
embryogenesis.
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Maintaining Hematopoietic
Stem Cells in the Vascular Niche
In this issue of Immunity, Sugiyama et al. (2006)
provide evidence that most bone-marrow hematopoi-
etic stem cells (HSCs) reside in vascular niches
containing reticular cells that secrete CXCL12, a
chemokine that promotes HSC maintenance.
Stem cells reside in specialized microenvironments
created by supporting cells that promote stem cell
maintenance through the production of factors that
regulate self-renewal and differentiation. Although the
identification of such niches offers the opportunity for
discovering key factors that regulate stem cell function,
these niches are just beginning to be localized and char-
acterized in mammalian tissues. For example, it has
been possible to highly purify mouse hematopoietic
stem cells (HSCs) for nearly 20 years, but only in recent
years have researchers begun to characterize the
niches in which HSCs reside.
Most work on HSC niches has focused on the endos-
teum, the inner surface of the bone that interfaces with
the bone marrow (Figure 1). The endosteum is covered
with osteoblasts (bone-generating cells) and osteo-
clasts (bone-degrading cells), which are thought to
secrete or activate a variety of factors that regulate
HSC function. Genetic manipulations that increase
osteoblast numbers in mice also increase the number
of HSCs in bone marrow (Calvi et al., 2003; Zhang
et al., 2003). Various factors, such as angiopoietin, that
appear to regulate the maintenance or the numbers of
HSCs in the bone marrow are expressed by osteoblasts
(Arai et al., 2004). Osteoclast activity (Kollet et al., 2006)
and the high amounts of calcium generated by bone
resorption (Adams et al., 2006) have also been impli-
cated in promoting HSC maintenance and localization
near the endosteum. There are also imaging data that
suggest that some HSCs reside at or near the endos-
teum (Nilsson et al., 2001; Zhang et al., 2003; Arai et al.,
2004; Kiel et al., 2005).
The endosteum, however, cannot be the whole story.
When osteoblasts are ablated from the bone marrow,
HSC frequency actually increases over time, whereas
differentiating cells disappear from the bone marrow
(Visnjic et al., 2004). This observation suggests that
HSCs may be less acutely dependent upon osteoblastsOttersbach, K., and Dzierzak, E. (2005). Dev. Cell 3, 377–
387.
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for their maintenance than differentiating cells. More-
over, other cells must be capable of creating HSC niches
because HSCs can be maintained for long periods of
time in extramedullary tissues like the spleen and liver,
tissues which do not contain endosteum or bone.
Until recently, attempts to directly localize HSCs within
the bone marrow depended either on markers whose
specificity was uncertain or on markers that were known
to yield low levels of purity (and therefore high levels of
uncertainty). As a result, it had not been possible to
precisely and systematically examine the localization of
untransplanted HSCs in situ. The fundamental problem
was that although it has long been possible to highly
purify HSCs by flow-cytometry, this involved combina-
tions of antibodies that are too complex for localizing
rare cells in tissue sections. This problem changed with
the discovery that HSCs can be highly purified with a sim-
ple two-color combination of SLAM family receptors:
45% of single CD150+CD482CD412 bone-marrow cells
(CD48 and CD41 are imaged with the same fluoro-
chrome) give long-term multilineage reconstitution upon
transplantation into irradiated mice (Kiel et al., 2005). The
localization of HSCs in hematopoietic tissues with these
markers revealed that about two-thirds of HSCs in the
bone marrow and in the spleen are adjacent to sinusoids
(Kiel et al., 2005). Sinusoids are specialized vessels that
allow cells in venous circulation to extravasate into he-
matopoietic tissues (Figure 1). Some bone-marrow
HSCs also localize to the endosteum or to other places.
The role of the endosteum in the regulation of HSC
function coupled with the localization of most HSCs to
sinusoids raised several questions. Do sinusoids create
vascular niches that regulate HSC maintenance, or are
the HSCs in these locations just on their way to the
endosteum (Figure 1)? In the bone marrow, are there
multiple niches that regulate distinct subsets of HSCs
in different ways, or are there common elements that
allow HSCs to be maintained by similar mechanisms
in both vascular and endosteal locations?
In this issue of Immunity, Sugiyama et al. provide
a mechanism for the maintenance of HSCs in vascular
niches as well as a functional link between the vascular
and endosteal niches (Sugiyama et al., 2006). They dem-
onstrate that sinusoids are surrounded by reticular cells
that secrete unusually high amounts of CXCL12 (also
known as stromal-cell-derived factor (SDF)-1), a chemo-
kine that is required for HSC maintenance. HSCs that
localized around sinusoids were usually in contact with
these reticular cells. Moreover, Sugiyama et al. also
